% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • headsupeyesclosed headsupeyesclosed Jun 19, 2013 1:44 PM Flag

    FDA autologous cell ruling is a step in the opposite direction imo

    I find it hard to believe that the FDA would rule against surgery using a patients own cells. What about skin grafts, should there be clinical trials for those too?
    The rest of the world will totally kick our a s s in this booming area of cosmetics.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Many US companies are moving into foreign markets because of FDA over regulation. Personalized medicine is the future and autogolous cell therapy will be an integral part of the medical landscape. Here is a ACT(autologous cell technology)projection that might actually be a low estimate:

      Global Autologous Cell Therapy Market worth $2.2 Billion by 2017

      There is a wide market potential and favorable landscape for adoption across many geographical locations of the world. During the forecast period, these technologies are expected to revolutionize the area of bio-pharma and personalized medicine. High incidence and lack of effective treatment for several diseases will drive the ACT technology in developed and developing nations.

      Investment activities, for past five years are actively held in research and developments, attracting interests of cell therapy industry firms, medical centers and academic institutions. ACT potential can be demonstrated by mergers, collaborations, acquisitions and partnerships that happened actively between the ACT technology developing companies in past three years. Development of sophisticated automation devices for cell expansion and culture process for use in the treatment is one of the emerging trends of ACT market.

0.00010.0000(0.00%)Oct 18 9:41 AMEDT